Enhanc3D Genomics

Silver Sponsor

Information

Enhanc3D Genomics has established a genome-wide 3D-sequencing platform (GenLink3D) using proprietary technology that can globally connect enhancer regions and GWAS (genome-wide association study) risk loci to their therapeutically targetable genes. Enhanc3D Genomics is applying this technology to multiple therapeutic areas, including immunology and immune-oncology. Enhanc3D Genomics is now actively seeking pharma partners and additional growth investors to further translate its unique “big-data” position in the field of functional genomics and precision medicine.

Exhibitor Profile
Biotechnology

Social media

Contact details

https://enhanc3dgenomics.com/
The Jeffreys Building
Cowley Road, CB4 0AP, Milton, England, United Kingdom

Sessions

3D Genomics: The Next Dimension of Discovery

Thursday, October 10, 2024 2:50 PM to 3:10 PM
Precision Medicine Diagnostics and Therapies
Hazel Jones · Enhanc3D Genomics

Team

Hazel Jones
Hazel Jones
Interim Chief Executive Officer and Chief Operating OfficerEnhanc3D Genomics
Kishen Chahwala
Kishen Chahwala
Business Development ManagerEnhanc3D Genomics

Log in